Final development and validation of the BOMET-QoL questionnaire for assessing quality of life in patients with malignant bone disease due to neoplasia

References

• Cella D, Chang CH, Lai JS et al. Advances in quality of life measurements in oncology patients. Seminars in Oncology 2002; 29(3 Suppl 8): 60–68.
   Google Scholar
• Badia X, Muriel C, Gracia A et al. [Validation of the Spanish version of the Brief Pain Inventory in patients with oncological pain.] Medicina Clínica 2003; 120: 52–59 [in Spanish].
   Google Scholar
• Tusquets I. Clínica, diagnóstico y evolución de las metástasis óseas: su importancia en la calidad de vida del paciente. Revisiones en Cáncer (Madrid) 2001; 15(Suppl. 1): 15–19.
   Google Scholar
• Martinez MJ, Roque M, Alonso-Coello P et al. Calcitonin for metastatic bone pain. Cochrane Database of Systematic Reviews 2003; 3: CD003223
   Google Scholar
• Lipton A. Bone metastases in breast cancer. Current Treatment Options in Oncology 2003; 4: 151–158.
   PubMedGoogle Scholar
• Reddi AH, Roodman D, Freeman C et al. Mechanisms of tumor metastasis to the bone: challenges and opportunities. Journal of Bone and Mineral Research 2003; 18: 190–194.
   PubMed Web of Science ®Google Scholar
• Radford M, Gibbons CL. Management of skeletal metastases. Hospital Medicine 2002; 63: 722–725.
   Google Scholar
• Bunting RW, Shea B. Bone metastasis and rehabilitation. Cancer 2001; 92(4 Suppl.): 1020–1028.
   Google Scholar
• Guo Y, Young B, Palmer JL et al. Prognostic factors for survival in metastatic spinal cord compression: a retrospective study in a rehabilitation setting. American Journal of Physical Medicine & Rehabilitation 2003; 82: 665–668.
   PubMed Web of Science ®Google Scholar
• Van Poznak CH. The use of bisphosphonates in patients with breast cancer. Cancer Control 2002; 9: 480–489.
   PubMedGoogle Scholar
• Pickering LM, Mansi JL. The role of bisphosphonates in breast cancer management: review article. Current Medical Research and Opinion 2002; 18: 284–295.
   PubMed Web of Science ®Google Scholar
• Hortobagyi GN. Moving into the future: treatment of bone metastases and beyond. Cancer Treatment Reviews 2005; 31(Suppl. 3): 9–18.
   Google Scholar
• Djulbegovic B, Wheatley K, Ross J et al. Bisphosphonates in multiple myeloma. Cochrane Database of Systematic Reviews 2002;3:CD003188.
   Google Scholar
• Osoba D. Health-related quality-of-life assessment in clinical trials of supportive care in oncology. Supportive Care in Cancer 2000;8:84–88.
   Google Scholar
• Porter GA, Skibber JM. Outcomes research in surgical oncology. Annals of Surgical Oncology 2000; 7: 367–375.
   Google Scholar
• Roila F, Cortesi E. Quality of life as a primary end point in oncology. Annals of Oncology 2001; 12(Suppl. 3): S3–S6.
   Google Scholar
• Schwartz CE, Sprangers MA. An introduction to quality of life assessment in oncology: the value of measuring patient- reported outcomes. Amercian Journal of Managed Care 2002; 18 (18 Suppl.): S550–S559.
   Google Scholar
• Ganz PA, Schag CA, Lee JJ et al. The CARES: a generic measure of health- related quality of life for patients with cancer. Quality of Life Research 1992; 1: 19–29.
   PubMedGoogle Scholar
• Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 1993; 85: 365–376.
   Google Scholar
• Cella DF, Tulsky DS, Gray G et al. The Functional Assessment of Cancer Therapy (FACT) scale: development and validation of the general measure. Journal of Clinical Oncology 1993; 11: 570–579.
   PubMed Web of Science ®Google Scholar
• Watson M, Law M, Maguire GP. Further development of a quality of life measure for cancer patients: the Rotterdam Symptom Checklist (revised). Psycho- oncology 1992; 1: 35–44.
   Google Scholar
• Adrover E, Allepuz J, Sureda A. Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with bone metastases (BOMET-QoL). Journal of Outcomes Research 2005; 9: 15–27.
   Google Scholar
• Badia X, Carné X. [Evaluation of quality of life in clinical trials.] Medicina Clinica 1998; 110: 550–556 [in Spanish].
   Google Scholar
• Nunnally JC, Bernstein IH. Psychometric Theory. New York, NY: McGraw-Hill, 1994.
   Google Scholar
• Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology 1982; 5: 649–655.
   PubMed Web of Science ®Google Scholar
• Cleeland CS. Research in cancer pain: what we know and what we need to know. Cancer 1991; 67: 823–827.
   Google Scholar
• Croker L, Algina J. Introdution to Classical and Modern Theory. Fort Worth, TX: Holt, Rinehart and Winston, 1986.
   Google Scholar
• Bond TG, Fox CM. Applying the Rasch model. In: Fundamental Measurement in the Human Sciencies. Mahwah, NJ: Lawrence Erlbaum Associates Publishers, 2001: 7–34.
   Google Scholar
• Fitzpatrick R, Fletcher A, Gore S et al. Quality of life measures in health care. I: Aplications and issues in assessment. British Medical Journal 1992; 305: 1074–1077.
   PubMed Web of Science ®Google Scholar
• Bland JM, Altman DG. Cronbach’s alpha. British Medical Journal 1997; 314: 572.
   PubMed Web of Science ®Google Scholar
• Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Controlled Clinical Trials 1991; 12 (4 Suppl.): 142S–158S.
   Google Scholar
• Yount S, Cella D, Banik D et al. Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI). Health and Quality of Life Outcomes 2003; 1: 69.
   PubMedGoogle Scholar
• Bezjak A, Taylor KM, Ng P et al. Quality of life information and clinical practice: the oncologist’s perpective. Cancer Prevention & Control 1998; 2: 230–235.
   PubMedGoogle Scholar
• Badia X, Díez-Pérez A, Lahoz R et al. The ECOS-16 questionnaire for the evaluation of health related quality of life in post- menopausal women with osteoporosis. Health and Quality of Life Outcomes 2004; 2: 41.
   PubMedGoogle Scholar
• Prieto L, Lamarca R, Santed R. Classical test theory versus Rasch analysis for health- related quality of life questionnaire reduction. Quality of Life Research 1999; 8: 652.
   Google Scholar
• Gómez Batiste X, Madrid F, Moreno F et al. Breakthrough cancer pain: prevalence and characteristics in patients in Catalonia, Spain. Journal of Pain and Symptom Management 2002: 24: 45–52.
   Google Scholar
• Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999; 81: 129–134.
   PubMed Web of Science ®Google Scholar
• Earlam S, Glover C, Fordy C et al. Relation between tumor size, quality of life and survival in patients with colorectal liver metastases. Journal of Clinical Oncology 1996; 14: 171–175.
   PubMed Web of Science ®Google Scholar
• Maisey NR, Norman A, Watson M et al. Baseline quality of life predicts survival in patients with advanced colorectal cancer. European Journal of Cancer 2002; 38: 1351–1357.
   PubMed Web of Science ®Google Scholar
• Mystakidou K, Tsilika E, Kouloulias V et al. The ‘Paliative Care Quality of Life Instrument (PQLI)’ in terminal cancer patients. Health and Quality of Life Outcomes 2004; 2: 8
   PubMedGoogle Scholar
• Osse BH, Vernooij MJ, Schade E et al. Towards a new clinical tool for needs assessment in the palliative care of cancer patients: the PNPC instrument. Journal of Pain and Symptom Management 2004; 28: 329–341.
   PubMed Web of Science ®Google Scholar
• Conroy T, Bleiberg H, Glimelius B. Quality of life in patientes with advanced colorectal cancer: what has been learnt? European Journal of Cancer 2003; 39: 287–294.
   PubMedGoogle Scholar
• Lundh Hagelin C, Seiger A, Furst CJ. Quality of life in terminal care—with special reference to age, gender and marital status. Supportive Care in Cancer 2006; 14: 320–328.
   Google Scholar